VolitionRX Q1 2024 GAAP EPS $(0.10) Beats $(0.11) Estimate, Sales $171.535K Miss $389.500K Estimate

VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $171.535 thousand which missed the analyst consensus estimate of $389.500 thousand by 55.96 percent. This is a 14.50 percent increase over sales of $149.808 thousand the same period last year.